 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval, u, n" \- `$ v) J
) D5 N+ r, s7 x7 \2 v3 yEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.5 r; k( D: f ~( ~8 R! N
( F' ~, J5 {. {* H0 ]9 Q4 wBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
& b* i5 m: V9 H+ b0 B* \/ p$ p+ x$ @
- {: A. I q1 n2 A3 T! o' e9 j! Y " i; ~ H6 k, Z$ j- x
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.& Q! v& H: o$ b- q! a& j6 b- R
* J+ ]0 R0 |. |5 T- d1 O1 FThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."3 e# g; c1 s% m# y% p+ n
8 n! L. t, f7 e g+ E5 V RThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.6 c( _" E8 K. F* R/ m8 i
! W L9 t6 w9 ?' g
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.( Z$ p* `/ d/ X0 {4 a5 [" |
1 Z2 }0 O# B) S; P4 x- n
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.8 i; Z! R* [* u/ i7 S& y
2 C0 i' C' l% H* p1 P4 P
"As a scientist, it's one of the highlights of my CAREER," Shan said.
3 w/ u S \+ z% S! `0 d v% S, o
+ z4 I% J& H4 p) j& s"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
" }* p6 ^, w- ^. d" J6 U9 R
2 A6 t I, E: c6 i) }It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.2 ^# @; n" ]# }8 w) W: b
" O0 H! _6 S# I% t2 k
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
$ s3 S- ~' p+ |. e/ x5 s- B: l5 L. c3 m f
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.1 c( N: Q3 q( w* b$ P6 q
$ J- _9 G& B0 F" G$ A, i' O' @. `; l, E; D k" {
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
+ K+ f1 i+ G# e+ c4 K- b
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
" W1 N: G; t$ h5 H4 R
发表于 2015-2-28 19:45
